320 related articles for article (PubMed ID: 26045440)
1. Mitochondrial Sirt3 Expression is Decreased in APP/PS1 Double Transgenic Mouse Model of Alzheimer's Disease.
Yang W; Zou Y; Zhang M; Zhao N; Tian Q; Gu M; Liu W; Shi R; Lü Y; Yu W
Neurochem Res; 2015 Aug; 40(8):1576-82. PubMed ID: 26045440
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-up-regulated mitochondrial movement regulator does not contribute to the APP/PS1 double transgenic mouse model of Alzheimer's disease.
Zou Y; Li Y; Yu W; Du Y; Shi R; Zhang M; Duan J; Deng Y; Tu Q; Dai R; Lü Y
Dement Geriatr Cogn Disord; 2013; 36(3-4):137-45. PubMed ID: 23900018
[TBL] [Abstract][Full Text] [Related]
3. Traumatic Brain Injury Increases the Expression of Nos1, Aβ Clearance, and Epileptogenesis in APP/PS1 Mouse Model of Alzheimer's Disease.
Miszczuk D; Dębski KJ; Tanila H; Lukasiuk K; Pitkänen A
Mol Neurobiol; 2016 Dec; 53(10):7010-7027. PubMed ID: 26671618
[TBL] [Abstract][Full Text] [Related]
4. Time-Dependent Increase of Chitinase1 in APP/PS1 Double Transgenic Mice.
Xiao Q; Shi R; Yang W; Zou Y; Du Y; Zhang M; Yu W; Lü Y
Neurochem Res; 2016 Jul; 41(7):1604-11. PubMed ID: 26935740
[TBL] [Abstract][Full Text] [Related]
5. Icariin, a phosphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling.
Jin F; Gong QH; Xu YS; Wang LN; Jin H; Li F; Li LS; Ma YM; Shi JS
Int J Neuropsychopharmacol; 2014 Jun; 17(6):871-81. PubMed ID: 24513083
[TBL] [Abstract][Full Text] [Related]
6. A neuronal model of Alzheimer's disease: an insight into the mechanisms of oxidative stress-mediated mitochondrial injury.
Sompol P; Ittarat W; Tangpong J; Chen Y; Doubinskaia I; Batinic-Haberle I; Abdul HM; Butterfield DA; St Clair DK
Neuroscience; 2008 Apr; 153(1):120-30. PubMed ID: 18353561
[TBL] [Abstract][Full Text] [Related]
7. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background.
Lok K; Zhao H; Shen H; Wang Z; Gao X; Zhao W; Yin M
Neurosci Lett; 2013 Dec; 557 Pt B():84-9. PubMed ID: 24176881
[TBL] [Abstract][Full Text] [Related]
9. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
10. APP/PS1 transgenic mice treated with aluminum: an update of Alzheimer's disease model.
Zhang QL; Jia L; Jiao X; Guo WL; Ji JW; Yang HL; Niu Q
Int J Immunopathol Pharmacol; 2012; 25(1):49-58. PubMed ID: 22507317
[TBL] [Abstract][Full Text] [Related]
11. Curcumin Ameliorates Memory Deficits by Enhancing Lactate Content and MCT2 Expression in APP/PS1 Transgenic Mouse Model of Alzheimer's Disease.
Lu WT; Sun SQ; Li Y; Xu SY; Gan SW; Xu J; Qiu GP; Zhuo F; Huang SQ; Jiang XL; Huang J
Anat Rec (Hoboken); 2019 Feb; 302(2):332-338. PubMed ID: 30312017
[TBL] [Abstract][Full Text] [Related]
12. Nitrosylation of Vesicular Transporters in Brain of Amyloid Precursor Protein/Presenilin 1 Double Transgenic Mice.
Wang Y; Zhou Z; Tan H; Zhu S; Wang Y; Sun Y; Li XM; Wang JF
J Alzheimers Dis; 2017; 55(4):1683-1692. PubMed ID: 27911305
[TBL] [Abstract][Full Text] [Related]
13. Sirtuin 3 attenuates amyloid-β induced neuronal hypometabolism.
Yin J; Li S; Nielsen M; Carcione T; Liang WS; Shi J
Aging (Albany NY); 2018 Oct; 10(10):2874-2883. PubMed ID: 30362958
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
Li F; Wei G; Bai Y; Li Y; Huang F; Lin J; Hou Q; Deng R; Zhou JH; Zhang SX; Chen DF
Brain Res; 2015 Nov; 1627():177-88. PubMed ID: 26423933
[TBL] [Abstract][Full Text] [Related]
15. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
[TBL] [Abstract][Full Text] [Related]
16. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.
Pedrós I; Petrov D; Allgaier M; Sureda F; Barroso E; Beas-Zarate C; Auladell C; Pallàs M; Vázquez-Carrera M; Casadesús G; Folch J; Camins A
Biochim Biophys Acta; 2014 Sep; 1842(9):1556-66. PubMed ID: 24887203
[TBL] [Abstract][Full Text] [Related]
17. Ligustilide Ameliorates Memory Deficiency in APP/PS1 Transgenic Mice via Restoring Mitochondrial Dysfunction.
Xu YJ; Mei Y; Qu ZL; Zhang SJ; Zhao W; Fang JS; Wu J; Yang C; Liu SJ; Fang YQ; Wang Q; Zhang YB
Biomed Res Int; 2018; 2018():4606752. PubMed ID: 30079347
[TBL] [Abstract][Full Text] [Related]
18. Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.
Chang KL; Wong LR; Pee HN; Yang S; Ho PC
Mol Neurobiol; 2019 Nov; 56(11):7267-7283. PubMed ID: 31016475
[TBL] [Abstract][Full Text] [Related]
19. Parallel age-associated changes in brain and plasma neuronal pentraxin receptor levels in a transgenic APP/PS1 rat model of Alzheimer's disease.
Bilousova T; Taylor K; Emirzian A; Gylys R; Frautschy SA; Cole GM; Teng E
Neurobiol Dis; 2015 Feb; 74():32-40. PubMed ID: 25449907
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen Sulfide Selectively Inhibits γ-Secretase Activity and Decreases Mitochondrial Aβ Production in Neurons from APP/PS1 Transgenic Mice.
Zhao FL; Qiao PF; Yan N; Gao D; Liu MJ; Yan Y
Neurochem Res; 2016 May; 41(5):1145-59. PubMed ID: 26708452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
